Skip to main content
. 2024 Jan 15;24:181. doi: 10.1186/s12889-024-17695-8

Table 4.

Characteristics of SARS-CoV-2 reinfections during the Omicron wave, using a 60-days interval between cases

Previously infected individuals at the start of the Omicron wave n (%) Reinfections n(%) Hazard ratio Adjusted Hazard ratio* Adjusted P-value*
Sex
 Male 131903 (51.1) 7367 (5.6) Ref. Ref. -
 Female 126204 (48.9) 7784 (6.2) 1.11 (1.08-1.15) 1.15 (1.11-1.18) <0.001
Age (in years)
 0-11 40110 (15.5) 2972 (7.4) 1.46 (1.39-1.54) 1.08 (1.01-1.15) 0.017
 12-17 39250 (15.2) 4080 (10.4) 1.92 (1.84-2.02) 1.67 (1.58-1.76) <0.001
 18-29 52590 (20.4) 3480 (6.6) 1.17 (1.11-1.22) 1.15 (1.10-1.21) <0.001
 30-44 56581 (21.9) 3059 (5.4) Ref. Ref. -
 45-54 32985 (12.8) 1117 (3.4) 0.62 (0.58-0.66) 0.72 (0.67-0.77) <0.001
 55-64 19229 (7.5) 340 (1.8) 0.32 (0.29-0.36) 0.40 (0.36-0.45) <0.001
 65-74 9799 (3.8) 70 (0.7) 0.13 (0.11-0.17) 0.20 (0.16-0.25) <0.001
 >=75 7563 (2.9) 33 (0.4) 0.08 (0.05-0.11) 0.11 (0.08-0.16) <0.001
County
 Agder 10035 (3.9) 508 (5.1) Ref. - -
 Innlandet 10805 (4.2) 413 (3.8) 0.73 (0.64-0.84)
 Møre og Romsdal 5789 (2.2) 114 (2.0) 0.39 (0.32-0.48)
 Nordland 5287 (2.0) 112 (2.1) 0.42 (0.34-0.51)
 Oslo 67501 (26.1) 5543 (8.2) 1.62 (1.48-1.77)
 Rogaland 14441 (5.6) 483 (3.3) 0.66 (0.58-0.74)
 Troms og Finnmark 9278 (3.6) 148 (1.6) 0.32 (0.26-0.38)
 Trøndelag 16329 (6.3) 669 (4.1) 0.81 (0.73-0.91)
 Vestfold og Telemark 15347 (6.0) 763 (5.0) 1.00 (0.89-1.12)
 Vestland 21439 (8.3) 840 (3.9) 0.79 (0.71-0.88)
 Viken 81856 (31.7) 5558 (6.8) 1.34 (1.23-1.47)
Country of birth
 Foreign 74037 (28.7) 4563 (6.2) Ref. - -
 Norway 179856 (69.7) 10568 (5.9) 0.99 (0.95-1.02)
 Unknown 4214 (1.6) 20 (0.5) 0.08 (0.05-0.12)
Risk group
 No comorbidity 224701 (87.1) 13796 (6.1) Ref. Ref. -
 Medium risk comorbidity 30137 (11.7) 1286 (4.3) 0.69 (0.65-0.73) 1.10 (1.03-1.16) 0.002
 High risk comorbidity 3269 (1.3) 69 (2.1) 0.34 (0.27-0.43) 0.78 (0.62-0.99) 0.041
Vaccine status
 Unvaccinated 93857 (36.4) 7971 (8.5) Ref. Ref. -
 Vaccinated with one dose <21 days earlier 2635 (1.0) 98 (3.7) 0.42 (0.34-0.51) 0.38 (0.31-0.46) <0.001
 Vaccinated with one dose >=21 days earlier 58983 (22.9) 4778 (8.1) 0.78 (0.75-0.81) 0.72 (0.69-0.75) <0.001
 Maximum of two doses 7-179 days prior 69593 (27.0) 1880 (2.7) 0.33 (0.31-0.35) 0.40 (0.38-0.42) <0.001
 Maximum of two doses ≥180 days prior 24572 (9.5) 292 (1.2) 0.16 (0.14-0.18) 0.37 (0.32-0.41) <0.001
 Three doses 8467 (3.3) 132 (1.6) 0.21 (0.17-0.25) 0.40 (0.33-0.48) <0.001
Most recent infection prior to Omicron wave
 Pre-alpha infection 42558 (16.5) 3012 (7.1) Ref. Ref. -
 Inter-wave pre-alpha/Alpha 30757 (11.9) 2423 (7.9) 1.12 (1.06-1.18) 0.93 (0.88-0.98) 0.006
 Alpha wave infection 42321 (16.4) 3406 (8.1) 1.14 (1.09-1.20) 0.87 (0.83-0.91) <0.001
 Inter-wave Alpha/Delta 10425 (4.0) 693 (6.7) 0.93 (0.86-1.02) 0.83 (0.76-0.90) <0.001
 Delta wave infection 132046 (51.2) 5617 (4.3) 0.77 (0.74-0.81) 0.56 (0.54-0.59) <0.001

Characteristics of SARS-CoV-2 reinfection cases during the Omicron wave, using a 60-days interval between cases. Hazard ratio estimates for reinfection using stratified Cox regression model in Norway 26 February 2020 - 31 January 2022 (n = 258 107)

*Sex, age group, risk group, vaccine status, the most recent infection prior to the Omicron wave was included in a multivariate model, stratifying for county of residence and country of birth